Janus Research Fund (JAMRX)

Large-Cap Growth Utilizing Our Analysts' Best Ideas



Inception Date5/3/1993
NAV (As of 6/29/15 )$45.13
Total Net Assets (As of 5/31/15)$4.81B
Annual Expense Ratio
(As of fiscal year end 9/30/14)
GROSS 0.80%
NET 0.80%

Performance (As of 3/31/15)
1 Year18.49%
3 Year17.94%
5 Year15.69%
10 Year10.15%
Morningstar (As of 5/31/15)
CategoryLarge Growth
Overall Rating™
(Based on risk-adjusted returns)

View All Ratings

1543 Funds Rated
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Quarterly Commentary - Q1 2015


Volatile markets gave way to gains in the U.S as the Federal Reserve appears in no hurry to raise interest rates.

Driven in part by healthy merger and acquisition activity, our selection of technology and health care stocks drove relative outperformance.

On a sector basis, our industrial holdings were the sole quarterly detractors.

We continue to expect a weak euro, a robust U.S. jobs market and a return to stimulative policies in China to be catalysts for equities well into 2015.